A detailed history of Pathstone Family Office, LLC transactions in Invitae Corp stock. As of the latest transaction made, Pathstone Family Office, LLC holds 157,972 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
157,972
Previous 81,333 94.23%
Holding current value
$0
Previous $91,000 3.3%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$0.6 - $1.53 $45,983 - $117,257
76,639 Added 94.23%
157,972 $94,000
Q2 2023

Jan 12, 2024

SELL
$1.05 - $1.63 $80,470 - $124,921
-76,639 Reduced 48.51%
81,333 $91,000
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $1,698 - $2,637
-1,618 Reduced 1.95%
81,333 $91,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.73 $56,510 - $128,561
47,092 Added 131.33%
82,951 $111,000
Q4 2022

Oct 23, 2023

SELL
$1.71 - $3.61 $52,900 - $111,678
-30,936 Reduced 46.31%
35,859 $66,000
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $52,900 - $111,678
-30,936 Reduced 46.31%
35,859 $66,000
Q3 2022

Oct 23, 2023

SELL
$1.9 - $8.63 $2,052 - $9,320
-1,080 Reduced 1.59%
66,795 $164,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $2,052 - $9,320
-1,080 Reduced 1.59%
66,795 $164,000
Q2 2022

Oct 23, 2023

SELL
$2.13 - $9.01 $28,665 - $121,256
-13,458 Reduced 16.55%
67,875 $165,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $8,221 - $34,778
-3,860 Reduced 5.38%
67,875 $166,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $356,678 - $885,449
56,796 Added 380.19%
71,735 $572,000
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $254,618 - $496,593
-17,321 Reduced 53.69%
14,939 $228,000
Q3 2021

Nov 16, 2021

BUY
$24.31 - $33.6 $48,449 - $66,964
1,993 Added 6.58%
32,260 $917,000
Q2 2021

Aug 31, 2021

BUY
$26.09 - $40.4 $562,161 - $870,498
21,547 Added 247.1%
30,267 $1.02 Million
Q1 2021

May 14, 2021

BUY
$33.06 - $56.93 $106,453 - $183,314
3,220 Added 58.55%
8,720 $333,000
Q2 2020

Aug 14, 2020

SELL
$11.71 - $30.29 $64,405 - $166,595
-5,500 Closed
0 $0
Q1 2020

Jun 11, 2020

BUY
$7.64 - $27.5 $42,020 - $151,250
5,500 New
5,500 $75,000
Q1 2020

May 07, 2020

SELL
$7.64 - $27.5 $25,212 - $90,750
-3,300 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $12,016 - $16,456
800 Added 32.0%
3,300 $532,000
Q3 2019

Nov 13, 2019

BUY
$18.85 - $27.5 $32,987 - $48,125
1,750 Added 233.33%
2,500 $48,000
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $13,027 - $19,702
750 New
750 $18,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.